Cargando…

Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers

The two main phytocannabinoids—delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)—have been extensively studied, and it has been shown that THC can induce transient psychosis. At the same time, CBD appears to have no psychotomimetic potential. On the contrary, emerging evidence for CBD's...

Descripción completa

Detalles Bibliográficos
Autores principales: Woelfl, Timo, Rohleder, Cathrin, Mueller, Juliane K., Lange, Bettina, Reuter, Anne, Schmidt, Anna Maria, Koethe, Dagmar, Hellmich, Martin, Leweke, F. Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693539/
https://www.ncbi.nlm.nih.gov/pubmed/33304282
http://dx.doi.org/10.3389/fpsyt.2020.576877
_version_ 1783614767891480576
author Woelfl, Timo
Rohleder, Cathrin
Mueller, Juliane K.
Lange, Bettina
Reuter, Anne
Schmidt, Anna Maria
Koethe, Dagmar
Hellmich, Martin
Leweke, F. Markus
author_facet Woelfl, Timo
Rohleder, Cathrin
Mueller, Juliane K.
Lange, Bettina
Reuter, Anne
Schmidt, Anna Maria
Koethe, Dagmar
Hellmich, Martin
Leweke, F. Markus
author_sort Woelfl, Timo
collection PubMed
description The two main phytocannabinoids—delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)—have been extensively studied, and it has been shown that THC can induce transient psychosis. At the same time, CBD appears to have no psychotomimetic potential. On the contrary, emerging evidence for CBD's antipsychotic properties suggests that it may attenuate effects induced by THC. Thus, we investigated and compared the effects of THC and CBD administration on emotion, cognition, and attention as well as the impact of CBD pre-treatment on THC effects in healthy volunteers. We performed a placebo-controlled, double-blind, experimental trial (GEI-TCP II; ClinicalTrials.gov identifier: NCT02487381) with 60 healthy volunteers randomly allocated to four parallel intervention groups, receiving either placebo, 800 mg CBD, 20 mg THC, or both cannabinoids. Subjects underwent neuropsychological tests assessing working memory (Letter Number Sequencing test), cognitive processing speed (Digit Symbol Coding task), attention (d2 Test of Attention), and emotional state (adjective mood rating scale [EWL]). Administration of CBD alone did not influence the emotional state, cognitive performance, and attention. At the same time, THC affected two of six emotional categories—more precisely, the performance-related activity and extraversion—, reduced the cognitive processing speed and impaired the performance on the d2 Test of Attention. Interestingly, pre-treatment with CBD did not attenuate the effects induced by THC. These findings show that the acute intake of CBD itself has no effect per se in healthy volunteers and that a single dose of CBD prior to THC administration was insufficient to mitigate the detrimental impact of THC in the given setting. This is in support of a complex interaction between CBD and THC whose effects are not counterbalanced by CBD under all circumstances.
format Online
Article
Text
id pubmed-7693539
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76935392020-12-09 Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers Woelfl, Timo Rohleder, Cathrin Mueller, Juliane K. Lange, Bettina Reuter, Anne Schmidt, Anna Maria Koethe, Dagmar Hellmich, Martin Leweke, F. Markus Front Psychiatry Psychiatry The two main phytocannabinoids—delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)—have been extensively studied, and it has been shown that THC can induce transient psychosis. At the same time, CBD appears to have no psychotomimetic potential. On the contrary, emerging evidence for CBD's antipsychotic properties suggests that it may attenuate effects induced by THC. Thus, we investigated and compared the effects of THC and CBD administration on emotion, cognition, and attention as well as the impact of CBD pre-treatment on THC effects in healthy volunteers. We performed a placebo-controlled, double-blind, experimental trial (GEI-TCP II; ClinicalTrials.gov identifier: NCT02487381) with 60 healthy volunteers randomly allocated to four parallel intervention groups, receiving either placebo, 800 mg CBD, 20 mg THC, or both cannabinoids. Subjects underwent neuropsychological tests assessing working memory (Letter Number Sequencing test), cognitive processing speed (Digit Symbol Coding task), attention (d2 Test of Attention), and emotional state (adjective mood rating scale [EWL]). Administration of CBD alone did not influence the emotional state, cognitive performance, and attention. At the same time, THC affected two of six emotional categories—more precisely, the performance-related activity and extraversion—, reduced the cognitive processing speed and impaired the performance on the d2 Test of Attention. Interestingly, pre-treatment with CBD did not attenuate the effects induced by THC. These findings show that the acute intake of CBD itself has no effect per se in healthy volunteers and that a single dose of CBD prior to THC administration was insufficient to mitigate the detrimental impact of THC in the given setting. This is in support of a complex interaction between CBD and THC whose effects are not counterbalanced by CBD under all circumstances. Frontiers Media S.A. 2020-11-13 /pmc/articles/PMC7693539/ /pubmed/33304282 http://dx.doi.org/10.3389/fpsyt.2020.576877 Text en Copyright © 2020 Woelfl, Rohleder, Mueller, Lange, Reuter, Schmidt, Koethe, Hellmich and Leweke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Woelfl, Timo
Rohleder, Cathrin
Mueller, Juliane K.
Lange, Bettina
Reuter, Anne
Schmidt, Anna Maria
Koethe, Dagmar
Hellmich, Martin
Leweke, F. Markus
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
title Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
title_full Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
title_fullStr Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
title_full_unstemmed Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
title_short Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
title_sort effects of cannabidiol and delta-9-tetrahydrocannabinol on emotion, cognition, and attention: a double-blind, placebo-controlled, randomized experimental trial in healthy volunteers
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693539/
https://www.ncbi.nlm.nih.gov/pubmed/33304282
http://dx.doi.org/10.3389/fpsyt.2020.576877
work_keys_str_mv AT woelfltimo effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers
AT rohledercathrin effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers
AT muellerjulianek effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers
AT langebettina effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers
AT reuteranne effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers
AT schmidtannamaria effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers
AT koethedagmar effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers
AT hellmichmartin effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers
AT lewekefmarkus effectsofcannabidiolanddelta9tetrahydrocannabinolonemotioncognitionandattentionadoubleblindplacebocontrolledrandomizedexperimentaltrialinhealthyvolunteers